dinaline has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| el-Beltagi, HM; Hagenbeek, A; Haroun, EA; Lelieveld, P; Martens, AC | 1 |
| Hagenbeek, A; Martens, AC; Weiershausen, U | 1 |
2 other study(ies) available for dinaline and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzamides; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cell Survival; Clone Cells; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Leukemia, Myeloid, Acute; Male; Phenylenediamines; Rats; Rats, Inbred BN; Tumor Cells, Cultured | 1993 |
Dinaline: a new oral drug against leukemia? Preclinical studies in a relevant rat model for human acute myelocytic leukemia (BNML).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Male; Neoplastic Stem Cells; Phenylenediamines; Rats; Rats, Inbred BN | 1988 |